Optipharm.CO.LTD Balance Sheet Health
Financial Health criteria checks 5/6
Optipharm.CO.LTD has a total shareholder equity of ₩23.8B and total debt of ₩10.9B, which brings its debt-to-equity ratio to 46%. Its total assets and total liabilities are ₩40.4B and ₩16.6B respectively.
Key information
46.0%
Debt to equity ratio
₩10.93b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩15.43b |
| Equity | ₩23.78b |
| Total liabilities | ₩16.64b |
| Total assets | ₩40.42b |
Recent financial health updates
Health Check: How Prudently Does Optipharm.CO.LTD (KOSDAQ:153710) Use Debt?
Mar 30
Optipharm.CO.LTD (KOSDAQ:153710) Has Debt But No Earnings; Should You Worry?
Dec 15Recent updates
Health Check: How Prudently Does Optipharm.CO.LTD (KOSDAQ:153710) Use Debt?
Mar 30What Kind Of Shareholders Hold The Majority In Optipharm.CO.,LTD's (KOSDAQ:153710) Shares?
Feb 23Should Optipharm.CO.LTD (KOSDAQ:153710) Be Disappointed With Their 52% Profit?
Jan 19
Optipharm.CO.LTD (KOSDAQ:153710) Has Debt But No Earnings; Should You Worry?
Dec 15Financial Position Analysis
Short Term Liabilities: A153710's short term assets (₩21.2B) exceed its short term liabilities (₩13.1B).
Long Term Liabilities: A153710's short term assets (₩21.2B) exceed its long term liabilities (₩3.5B).
Debt to Equity History and Analysis
Debt Level: A153710 has more cash than its total debt.
Reducing Debt: A153710's debt to equity ratio has increased from 11.7% to 46% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A153710 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A153710 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 35.4% each year